![Paul Waymack](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Waymack
Corporate Officer/Principal chez Marillion Pharmaceuticals, Inc.
Provenance du réseau au premier degré de Paul Waymack
Entité | Type d'entité | Industrie | |
---|---|---|---|
Marillion Pharmaceuticals, Inc.
![]() Marillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Marillion Pharmaceuticals, Inc. provides cancer pharmaceuticals. It focuses on the development and commercialization of novel therapeutics for the treatment of cancers and for care in oncology. The firm products include Lu-AMBA, Pilobuc, and MN-201. The company was founded by Jerry Glickson, Zahed Subhan, and Gang Zheng in February 2005 and is headquartered in Radnor, PA.
2
| Private Company | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Paul Waymack via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
The Biotechnology Greenhouse Corp. of Southeastern PA
![]() The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Chief Executive Officer | |
ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Aston | College/University | Graduate Degree | |
University of Sunderland | College/University | Undergraduate Degree | |
Melior Discovery, Inc.
![]() Melior Discovery, Inc. Miscellaneous Commercial ServicesCommercial Services Melior Discovery, Inc. provides phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services. It offers theraTRACE, an indications discovery platform of multiplexed in vivo models that focus on various indications/therapeutic areas, including neurodegenerative disease and psychiatry, inflammation, acute and chronic pain, metabolic disease, gastrointestinal & urology, cardiovascular disease, and dermatology aspects. The company was founded by Andrew G. Reaume and Michael S. Saporito in 2005 and is headquartered in Exton, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Bradford | College/University | Masters Business Admin | |
University of Leeds | College/University | Doctorate Degree | |
Gemini Genomics Plc
![]() Gemini Genomics Plc Miscellaneous Commercial ServicesCommercial Services Part of Laboratory Corp. of America Holdings, Gemini Genomics Plc is a British company that provides clinical genomics services. The company is based in Cambridge, UK. The company was founded by Michael Edward Fitzgerald, Paul James Kelly. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
HealthPro BioVentures LLC
![]() HealthPro BioVentures LLC Investment ManagersFinance Founded in 2003, HealthPro BioVentures LLC is a life sciences investment bank and strategic advisory firm headquartered in New York City | Investment Managers | Corporate Officer/Principal | |
Mebias Discovery, LLC
![]() Mebias Discovery, LLC Pharmaceuticals: MajorHealth Technology Mebias Discovery, LLC engages in discovering drugs. The company was founded by Lawrence C. Kuo, Brett A. Tounge and Shariff S. Bayoumy in January 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
ANNOVIS BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
PhenoTech, Inc.
![]() PhenoTech, Inc. BiotechnologyHealth Technology PhenoTech, Inc. develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications. It offers blood diagnostic reagents, such as nanoscale emissive antibody-complexes for typing reagents for pre-transfusion testing. The company was founded by Eric Ostertag in 2003 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Jenrin Discovery LLC
![]() Jenrin Discovery LLC Pharmaceuticals: MajorHealth Technology Jenrin Discovery, Inc. develops therapeutics for chronic diseases. It provides therapeutics for various diseases, including obesity, diabetes, and autoimmune and inflammatory disorders. The company was founded by John F. McLeroy on April 17, 2007 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
University of Virginia | College/University | Graduate Degree | |
University of West London | College/University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 14 |
Royaume-Uni | 7 |
Danemark | 2 |
Sectorielle
Health Technology | 11 |
Consumer Services | 7 |
Finance | 3 |
Commercial Services | 3 |
Opérationnelle
Director/Board Member | 7 |
Corporate Officer/Principal | 6 |
Chief Executive Officer | 4 |
Graduate Degree | 3 |
Chief Investment Officer | 1 |
Relations les plus connectées
Insiders | |
---|---|
Zahed Subhan | 13 |
Barbara S. Schilberg | 10 |
- Bourse
- Insiders
- Paul Waymack
- Connexions Sociétés